The Role of CD40 in Allergic Rhinitis and Airway Remodelling

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Control</td><td class="align_center">AR</td><td class="align_center">Intravenous CD40 siRNA</td><td class="align_center">Nasal CD40 siRNA</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">PAS staining (goblet cells number)</td><td class="align_center">75.70 (35.75-88.25)</td><td class="align_center">55.00 (42.50-98.75)</td><td class="align_center">73.00 (51.50-109.50)</td><td class="align_center">53.00 (41.50-65.50)</td></tr><tr><td class="align_left">MT staining (percentage of collagen deposition)</td><td class="align_center">7.269 (6.429-8.285)</td><td class="align_center">19.369 (15.760-21.596)</td><td class="align_center">8.521 (7.565-10.088)</td><td class="align_center">9.306 (8.305-10.247)</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Histopathology results of tissue remodelling.</div>

Mediators of Inflammation

tab2

Table 2

Table 2: The Role of CD40 in Allergic Rhinitis and Airway Remodelling 